Literature DB >> 19339416

MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement.

Kyongtae T Bae1, Cheng Tao, Fang Zhu, James E Bost, Arlene B Chapman, Jared J Grantham, Vicente E Torres, Lisa M Guay-Woodford, Catherine M Meyers, William M Bennett.   

Abstract

BACKGROUND AND OBJECTIVES: To evaluate the inter- and intrareader reliability and the effect of gadolinium enhancement on kidney volume measurements obtained from pre- and postgadolinium T1 MR images in patients with autosomal dominant polycystic kidney disease (ADPKD). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Twenty subjects were randomly selected with approximately equal frequency from three kidney-size groups. Pre- and postgadolinium 3D T1 (pre-T1, post-T1) MR images were obtained. The stereology method was applied to segment and measure kidney volumes. The measurement process was repeated at two-wk intervals by two radiologists. Reliability was assessed with correlation coefficients. Intra- and inter-reader bias and measure differences were assessed with paired T-tests. The size effect on the pre- and post-T1 measurements was evaluated with one-way ANOVA.
RESULTS: The intra- and inter-reader reliability was extremely high in all measurements. No systematic intrareader bias but a small inter-reader bias for the post-T1 measurements was observed. All kidney volumes measured on the pre- and post-T1 images were highly correlated with each other for both readers. The post-T1 volumes were significantly higher than pre-T1 volumes. While the post-pre volume differences were relatively constant across the three kidney-size groups, the post-pre percent volume differences were significantly smaller as the size of the kidney increased.
CONCLUSIONS: Kidney volume measurements can be made with minimum intra- and inter-reader variability on both pre- and post-T1 MR images. Kidney volumes measured on the pre-T1 were smaller than those on post-T1, and percent differences between pre-T1 and post-T1 kidney volumes decreased with increasing kidney size.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339416      PMCID: PMC2666436          DOI: 10.2215/CJN.03750708

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  33 in total

1.  Quantitative MRI: a reliable protocol for measurement of cerebral gyrification using stereology.

Authors:  Lisa Ronan; Colin P Doherty; Norman Delanty; John Thornton; Mary Fitzsimons
Journal:  Magn Reson Imaging       Date:  2006-01-06       Impact factor: 2.546

2.  Renal structure and hypertension in autosomal dominant polycystic kidney disease.

Authors:  P A Gabow; A B Chapman; A M Johnson; D J Tangel; I T Duley; W D Kaehny; M Manco-Johnson; R W Schrier
Journal:  Kidney Int       Date:  1990-12       Impact factor: 10.612

3.  Stereology, a new quantitative morphological approach to study prostatic function and disease.

Authors:  G Bartsch
Journal:  Eur Urol       Date:  1977       Impact factor: 20.096

4.  The diagnosis and prognosis of autosomal dominant polycystic kidney disease.

Authors:  P S Parfrey; J C Bear; J Morgan; B C Cramer; P J McManamon; M H Gault; D N Churchill; M Singh; R Hewitt; S Somlo
Journal:  N Engl J Med       Date:  1990-10-18       Impact factor: 91.245

5.  The clinical utility of renal concentrating capacity in polycystic kidney disease.

Authors:  P A Gabow; W D Kaehny; A M Johnson; I T Duley; M Manco-Johnson; D C Lezotte; R W Schrier
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

Review 6.  Extracellular gadolinium-based contrast media: an overview.

Authors:  Marie-France Bellin; Aart J Van Der Molen
Journal:  Eur J Radiol       Date:  2008-03-20       Impact factor: 3.528

7.  Polycystic kidney disease: prospective analysis of nonazotemic patients and family members.

Authors:  P A Gabow; D W Iklé; J H Holmes
Journal:  Ann Intern Med       Date:  1984-08       Impact factor: 25.391

8.  Volume of polycystic kidneys during reduction of renal function.

Authors:  H S Thomsen; J K Madsen; J H Thaysen; K Damgaard-Petersen
Journal:  Urol Radiol       Date:  1981

9.  Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.

Authors:  Kyongtae T Bae; Fang Zhu; Arlene B Chapman; Vicente E Torres; Jared J Grantham; Lisa M Guay-Woodford; Deborah A Baumgarten; Bernard F King; Louis H Wetzel; Philip J Kenney; Marijn E Brummer; William M Bennett; Saulo Klahr; Catherine M Meyers; Xiaoling Zhang; Paul A Thompson; J Philip Miller
Journal:  Clin J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 8.237

10.  ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis.

Authors:  Henrik S Thomsen
Journal:  Eur Radiol       Date:  2007-10       Impact factor: 7.034

View more
  29 in total

1.  Blood pressure in early autosomal dominant polycystic kidney disease.

Authors:  Robert W Schrier; Kaleab Z Abebe; Ronald D Perrone; Vicente E Torres; William E Braun; Theodore I Steinman; Franz T Winklhofer; Godela Brosnahan; Peter G Czarnecki; Marie C Hogan; Dana C Miskulin; Frederic F Rahbari-Oskoui; Jared J Grantham; Peter C Harris; Michael F Flessner; Kyongtae T Bae; Charity G Moore; Arlene B Chapman
Journal:  N Engl J Med       Date:  2014-11-15       Impact factor: 91.245

2.  Safety and Efficacy of A High Performance Graphene-Based Magnetic Resonance Imaging Contrast Agent for Renal Abnormalities.

Authors:  Shruti Kanakia; Jimmy Toussaint; Praveen Kukarni; Stephen Lee; Sayan Mullick Chowdhury; Slah Khan; Sandeep K Mallipattu; Kenneth R Shroyer; William Moore; Balaji Sitharaman
Journal:  Graphene Technol       Date:  2016-08-03

3.  Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.

Authors:  Alan S L Yu; Chengli Shen; Douglas P Landsittel; Jared J Grantham; Larry T Cook; Vicente E Torres; Arlene B Chapman; Kyongtae Ty Bae; Michal Mrug; Peter C Harris; Frederic F Rahbari-Oskoui; Tiange Shi; William M Bennett
Journal:  Kidney Int       Date:  2019-03-04       Impact factor: 10.612

Review 4.  [Overview: liver tumors].

Authors:  Ivo Graziadei
Journal:  Wien Med Wochenschr       Date:  2013-01-30

Review 5.  Methodological issues in clinical trials of polycystic kidney disease: a focused review.

Authors:  Ioan-Andrei Iliuta; Abhijat Kitchlu; York Pei
Journal:  J Nephrol       Date:  2016-11-17       Impact factor: 3.902

6.  Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Alan S L Yu; Chengli Shen; Douglas P Landsittel; Peter C Harris; Vicente E Torres; Michal Mrug; Kyongtae T Bae; Jared J Grantham; Frederic F Rahbari-Oskoui; Michael F Flessner; William M Bennett; Arlene B Chapman
Journal:  Kidney Int       Date:  2017-12-28       Impact factor: 10.612

Review 7.  Why kidneys fail in autosomal dominant polycystic kidney disease.

Authors:  Jared J Grantham; Sumanth Mulamalla; Katherine I Swenson-Fields
Journal:  Nat Rev Nephrol       Date:  2011-08-23       Impact factor: 28.314

Review 8.  Looking at the (w)hole: magnet resonance imaging in polycystic kidney disease.

Authors:  Max Christoph Liebau; Andreas Lucas Serra
Journal:  Pediatr Nephrol       Date:  2012-12-14       Impact factor: 3.714

Review 9.  Imaging for the prognosis of autosomal dominant polycystic kidney disease.

Authors:  Kyongtae T Bae; Jared J Grantham
Journal:  Nat Rev Nephrol       Date:  2010-02       Impact factor: 28.314

Review 10.  Radiologic imaging of the renal parenchyma structure and function.

Authors:  Nicolas Grenier; Pierre Merville; Christian Combe
Journal:  Nat Rev Nephrol       Date:  2016-04-12       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.